New Ulcerative Colitis Drug Study Results To Be Presented By Avaxia Biologics

New Ulcerative Colitis Drug Study Results To Be Presented By Avaxia Biologics
New research and development news for ulcerative colitis (UC) indicates that a promising, new front-line therapy for the disease that can be taken in pill form may be making its way toward becoming a viable option. AvaxiaBiologics Inc. recently stated in a press release that they will announce the results from a Phase 1b clinical trial to assess

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *